Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04555720 · ClinicalTrials.gov registry record · NA

The Benchmark Clinic: An Interdisciplinary Comprehensive Care Model for People With Parkinson Disease

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
61
Enrollment target

NCT04555720: Completed NA study, sponsored by Duke University.

NCT04555720 is a NA study that has completed, run by Duke University. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04555720, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target

Study Summary

The purpose of this study is to determine if an interdisciplinary clinic can help people with Parkinson's disease care for themselves, improve their ability to follow recommended treatments, and have fewer problems like falls or visits to the emergency room. Participants will be randomly assigned to receive either care from the interdisciplinary clinic or standard neurological specialist care. This study involves questionnaires both before and 3 months after participation in a one time interdisciplinary care clinic or standard care depending on which type of care the participant is randomized to. Participants will be in the study for up to 6 months. The study will end upon completion of questionnaires about 3 months after treatment with the interdisciplinary care clinic or standard care.

Primary Outcome

Title of scale: Self-efficacy Scale for Chronic Diseases. This is a validated scale. Minimum score is 6, Maximum score is 60. Higher score is a better outcome.

Interventions

  • BEHAVIORAL Interdisciplinary Visit

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2021-02-03
Est. Completion 2021-11-01
Phase NA
Duke University

1,725 total trials

What the finished NCT04555720 record still lists

NCT04555720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Interdisciplinary Visit is the first listed.

NCT04555720 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04555720 about?

NCT04555720 is a clinical study titled "The Benchmark Clinic: An Interdisciplinary Comprehensive Care Model for People With Parkinson Disease". The purpose of this study is to determine if an interdisciplinary clinic can help people with Parkinson's disease care for themselves, improve their ability to follow recommended treatments, and have fewer problems like falls or visits to the emergency room. Participants will be randomly assigned t...

What is the current status of trial NCT04555720?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2021-02-03. Estimated completion is 2021-11-01.

What interventions are being tested in trial NCT04555720?

The interventions under investigation include: Interdisciplinary Visit (BEHAVIORAL).

Who is sponsoring clinical trial NCT04555720?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04555720's enrollment target sits among peer trials

61 1164th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04555720, the US trial registry maintained by the National Library of Medicine. NCT04555720 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.